We systematically summarize recent data on various CD4+ T cells activation in systemic sclerosis (SSc), and discuss their potential role in promoting inflammaton and fibrosis.
The T helper cell 17 (Th17)/regulatory T cell (Treg) paradigm is one of the hallmarks of SSc, as Th17-type cytokines can both arouse inflammation and fibrosis. Furthermore, several studies have reported new T cell subsets in the peripheral blood, serum and skin lesions of SSc individuals, including Th9, Th22 cells and their iconic cytokines.
Moreover, we speculate that the newly-discovered T follicular helper (Tfh) cells may be also involved in the pathogenesis of SSc.